Pfizer CEO On Next Steps For Coronavirus Vaccine And His Controversial Stock Trade Albert Bourla, head of the pharmaceutical giant, discuss...
Pfizer CEO On Next Steps For Coronavirus Vaccine And His Controversial Stock Trade
Albert Bourla, head of the pharmaceutical giant, discusses plans for distributing its vaccine, which it says is 95% effective, and explains the timing of his $5.6 mllion sale of Pfizer stock.
Read more on NPR
Albert Bourla, head of the pharmaceutical giant, discusses plans for distributing its vaccine, which it says is 95% effective, and explains the timing of his $5.6 mllion sale of Pfizer stock.
Read more on NPR
